Rochelle Walensky just announced that she has COVID 19. She received the bivalent booster exactly one month ago at a CVS pharmacy. Right now she's probably in the window where the booster exerts the greatest protective effect it could possibly exert, yet still: look what happened.
If you ask the CDC director, “ What is the vaccine efficacy of the bivalent booster you have received? What is it for any symptomatic disease? What is it for severe disease?” She won't be able to answer.
That's because the leadership at the White House has permitted this product to come to the US market without any credible evidence that it has any vaccine effectiveness. We simply don't have human randomized data for clinical endpoints. All we have is human data on antibody titers, which is a surrogate endpoint of no value in the current moment.
No comments:
Post a Comment